Health News

WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca’s ETCAMAH® (camizestrant) in combination with a cyclin-dependent kinase (CDK) 4/6 inhibitor (abemaciclib, palbociclib or ribociclib) has been approved in the US for the treatment of adult patients with hormone receptor (HR)-positive, HER2-negative, locally advanced or metastatic breast cancer upon detection of ESR1 mutation during aromatase inhibitor (AI) and CDK4/6 inhibitor therapy, based on a US Food and Drug Administration (FDA)-authorized test...

PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that the U.S. Food and Drug Administration (FDA) has approved Guardant360® CDx as a companion diagnostic (CDx) to identify patients with hormone receptor (HR)-positive, HER2-negative advanced or metastatic breast cancer harboring tumors with ESR1 mutations before radiographic progression who may benefit from treatment with ETCAMAH™ (camizestrant), AstraZeneca’s next-gener...

BOULDER, Colo.--(BUSINESS WIRE)--Laird Superfood, Inc. (NYSE American: LSF) today announced the appointment of Mark Johnson as Chief Financial Officer, effective October 1, 2026. Mr. Johnson will report to Chief Executive Officer Jason Vieth and will serve as the Company’s principal financial officer and principal accounting officer.Mr. Johnson brings more than 25 years of finance leadership across public consumer packaged goods and private equity-backed companies. He joins Laird Superfood from...

CARLSBAD, Calif.--(BUSINESS WIRE)--Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) partner Novartis today announced that the pelacarsen Phase 3 Lp(a)HORIZON study, a pioneering cardiovascular outcomes trial, did not meet its primary endpoint of reducing the risk of cardiovascular events, a composite of cardiovascular death, non-fatal myocardial infarction, non-fatal stroke, and urgent coronary revascularization requiring hospitalization, compared to placebo. Consistent with previous studies, substan...

NEW YORK--(BUSINESS WIRE)--Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced that the Compensation Committee of the Company’s Board of Directors approved the grant of non-qualified stock options to purchase an aggregate of 38,330 shares of the Company’s common stock to two new employees (the “Inducement Grants”) on September 1, 2026 (the “Grant Date”). The Indu...

SALT LAKE CITY--(BUSINESS WIRE)--Three Trailblazers Join PSFF Board and Global Clinical Lab 2.0 Movement...

PORTLAND, Ore. & LITTLE ROCK, Ark.--(BUSINESS WIRE)--The Arkansas Insurance Department has approved the strategic affiliation between Arkansas Blue Cross and Blue Shield and Cambia Health Solutions. The affiliation will enable greater capabilities for access to care that is simpler and more affordable, while maintaining the strong local commitment that has served Arkansans for more than 78 years. The affiliation will unify operations and enable the organizations to share best practices and expe...

CHEVY CHASE, Md.--(BUSINESS WIRE)--With Novartis & Exelixis, Caring Men Global expands "Strong Caregivers, Stronger Survivors" to support male caregivers of cancer survivors....

SAN FRANCISCO--(BUSINESS WIRE)--Vagaro, the leading software and app for medical spas and beauty, wellness, and fitness businesses, announced the launch of enhanced SOAP Notes and Custom Fields, two strategic HIPAA-compliant features designed to help med spas streamline clinical workflows, improve documentation accuracy, and better manage day-to-day operations.As medical spas scale their services, locations, and patient volume, providers face a familiar tension between detailed treatment documen...

SAN FRANCISCO--(BUSINESS WIRE)--A healthcare AI company PhyxUp Health launches PhyxUp Billing, an AI-powered solution automating RTM revenue cycle workflows for outpatient practices....